Psychiatry and Clinical Psychopharmacology
Case Report

Opioid false-positivity in urine drug screening: levomepromazine cross-reactivity

1.

Department of Psychiatry and Mental Health, Vila Nova de Gaia Healthcare Center, Vila Nova de Gaia, Portugal

Psychiatry and Clinical Psychopharmacology 2017; 27: 93-95
DOI: 10.1080/24750573.2017.1293254
Read: 860 Downloads: 476 Published: 10 February 2021

Urine drug screening false-positives are reported for several drugs, which may lead to clinical misdiagnosis and have negative consequences for the patient on personal and social grounds, if not identified. False-positives for opiates are rare, but we report a case where high-dose levomepromazine was very likely involved.

Files
EISSN 2475-0581